UJI TOKSIK SUSPENSI SEL PUNCA CD34+ MANUSIA PADA TIKUS SPRAGUE DAWLEY (SD)
DOI:
https://doi.org/10.33533/jpm.v8i2.679Keywords:
toxicity test, stem cell, CD34 cell, scaffold, growth factors, naive rats, tissue engineeringAbstract
Introduction : Research of CD34+ cells intervention to rats is not yet done. This researchis the latest research which investigated the toxic reaction of CD34+ hematopoietic stem cell intervention in non engineered rats.
Methods : 3 Sprague Dawley rats, male, 7 months, 285+18,5 g. Rat 1 : received intraartricular injection of human peripheral blood CD34+ cells (105 cells). Rat 2 : received intraartricular injection of human cord blood CD34+ cells (105 cells). Rat 3 : received intraartricular injection of human cord blood CD34+ cells (106 cells), hyaluronic acid and grown factors. All rats were examined hematological, blood chemistry parameters and microscopic of the liver and kidney.
Result : All rats showed good condition. There is slight increasing parameter in hematological and blood chemistry but liver and kidney in normal microscopic condition. No hiperacute rejection reaction : edema, systemic bleeding. There is no hyper acute and acute reaction.
Conclusion : Human CD34+ cells suspension with or without scaffold and growth factors does not cause toxicity reaction in naïve Sprague Dawley rats.
References
(1) Kim BS, Park KI, Hosiba T, et al. Design of artificial extracellular
matrices for tissue engineering. J Propolymsci. 2011;36(2):238-
Doi:10.1016/j.prog.polymsci.2010.10.001.
(2) Khan WS, Malik AA, Hardingham TE. Stem cell applications and
tissue engineering approaches insurgical practice. J Perioper
Pract. 2009;19(4):130-5.
(3) Grayson LW, Martens PT, Eng MG, Radisic M, Vunjak GN.
Biomimetic approach to tissue engineering. Semin Cell Dev Biol.
;20(6):665-73. Doi:10.1016/j.semcdb.2008.12.008.
(4) Burdick JA, Novakovic GV. Enginereed microenvirontments for
controlled stem cell differentiation. Tissue Eng Part A.
;15(2):205-19. Doi:10.1089/ten.tea.2008.0131.
(5) Gelse K, Schneider H. Ex vivo gene therapy approaches to
cartilage repair. J. Addr. 2006;58(2):259-84.
Doi:10.1016/j.addr.2006.01.019.
(6) Chiang H, Jiang CC. Repair of articular cartilage defect: Review
and perspectives. J Formos Med Assoc. 2009;108(2):87-101.
(7) Haleem AM, Chu CR. Advances in tissue engineering techniques
for articular cartilage repair. Optechorthopaedics.
;20(2):76-89. Doi :10.1053/j.oto.2009.10.004.
(8) Chen FH, Rousche KT, Tuan RS. Technology insight: adult stem
cells in cartilage regeneration and tissue engineering. Nat Clin
Pract Rheumatol. 2006;2(7):373-82.
Doi:10.1038/ncprheum0216.
(9) Gelse K, Schneider H. Ex vivo gene therapy approaches to
cartilage repair. J.Addr. 2006;58(2):259-84.
Doi:10.1016/j.addr.2006.01.019.
(10) Richardson JB, Lim JTK, Hui JHP, Lee EH. Stem cells and
cartilage. In : Bongso A, Eng HL, editors. Stem Cell from Bench
to Beside Singapore : World Scientific Publishing Co. Pte.
Ltd.;2005.p.466-493.
Downloads
Published
How to Cite
Issue
Section
License
Copyright Notice
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
Note :
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).